review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1032012522 |
P356 | DOI | 10.1007/BF03168827 |
P698 | PubMed publication ID | 11491050 |
P2093 | author name string | Kay E | |
Kelly CJ | |||
Bouchier-Hayes D | |||
McLaughlin R | |||
P2860 | cites work | Two distinct cytokines released from a human aminoacyl-tRNA synthetase | Q22009128 |
FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis | Q24307362 | ||
Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c | Q24309066 | ||
The receptor for the cytotoxic ligand TRAIL | Q24310481 | ||
Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95 | Q24314819 | ||
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
Disruption of epithelial cell-matrix interactions induces apoptosis | Q24673611 | ||
Apoptosis in the pathogenesis and treatment of disease | Q28235731 | ||
Preconditioning protects ischemic rabbit heart by protein kinase C activation | Q28252142 | ||
Apoptosis: an overview | Q28254960 | ||
Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins | Q28284116 | ||
A death-domain-containing receptor that mediates apoptosis | Q28297670 | ||
The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system : relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes | Q28572498 | ||
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages | Q29616355 | ||
The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis | Q29616513 | ||
Bcl-2 functions in an antioxidant pathway to prevent apoptosis | Q29620401 | ||
Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization | Q33895700 | ||
Reperfusion injury induces apoptosis in rabbit cardiomyocytes | Q34190792 | ||
Genetic control of programmed cell death in the nematode C. elegans. | Q34196702 | ||
The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta | Q34201359 | ||
Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques | Q34218450 | ||
Induction of myocardial nitric oxide synthase by cardiac allograft rejection | Q34229260 | ||
Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation | Q34245495 | ||
C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. | Q34322094 | ||
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. | Q34358996 | ||
The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide | Q34399432 | ||
The role of chemical mediators released by the endothelium in the control of the cardiovascular system | Q35382116 | ||
Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. | Q41627458 | ||
The importance of oxidative stress in apoptosis | Q41646668 | ||
Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia | Q41714603 | ||
Apoptosis. The role of the endonuclease | Q41843550 | ||
Caspase activity is required for commitment to Fas-mediated apoptosis. | Q42623004 | ||
Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases | Q42947736 | ||
Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. | Q44952270 | ||
In vivo gene transfection of human endothelial cell nitric oxide synthase in cardiomyocytes causes apoptosis-like cell death. Identification using Sendai virus-coated liposomes | Q45762805 | ||
Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy | Q45882968 | ||
Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats | Q47341587 | ||
American College of Cardiology 45th Annual Scientific Session, Orlando, Florida, March 24 to 27, 1996. | Q50618509 | ||
Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. | Q50927284 | ||
Programmed cell death and Bcl-2 protection in very low oxygen. | Q52208882 | ||
Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. | Q52509768 | ||
BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. | Q52514947 | ||
Thymocyte apoptosis induced by p53-dependent and independent pathways. | Q54242475 | ||
Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. | Q54374888 | ||
Apoptosis in the heart. | Q55066668 | ||
Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia | Q57384620 | ||
Evidence of Apoptosis in Arrhythmogenic Right Ventricular Dysplasia | Q58150495 | ||
Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques | Q61709815 | ||
The bcl-2 gene product prevents programmed cell death of ventricular myocytes | Q64382303 | ||
Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells | Q67803170 | ||
Serum interleukin 6 levels become elevated in acute myocardial infarction | Q68034819 | ||
The Role of Apoptosis in the Response of Cells and Tumours to Mild Hyperthermia | Q68292697 | ||
Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers | Q68413626 | ||
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure | Q68524243 | ||
Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart | Q71102878 | ||
Forging a path to cell death | Q71242589 | ||
Apoptosis and DNA fragmentation in the bulbus cordis of the developing rat heart | Q71358941 | ||
Apoptosis in myocytes in end-stage heart failure | Q71554187 | ||
The aortic tunica media in aging rats | Q71571849 | ||
Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase | Q71613841 | ||
Apoptosis in target organs of hypertension | Q71740108 | ||
Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart | Q71741492 | ||
Programmed Cell Death and Expression of the Protooncogene bcl-2 in Myocytes during Postnatal Maturation of the Heart | Q71940627 | ||
Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans | Q72001453 | ||
Cytological and cytochemical studies on cell death and digestion in the foetal rat foot: the role of macrophages and hydrolytic enzymes | Q72071503 | ||
Oxidative stress-induced apoptosis prevented by Trolox | Q72150904 | ||
Apoptosis in human atherosclerosis and restenosis | Q72256402 | ||
The cellular basis of dilated cardiomyopathy in humans | Q72262203 | ||
Apoptosis (programmed cell death) in arteries of the neonatal lamb | Q72455487 | ||
Checkpoints of dueling dimers foil death wishes | Q72790765 | ||
The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents | Q72800599 | ||
Apoptosis in human acute myocardial infarction | Q73012582 | ||
L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice | Q73012628 | ||
Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury | Q73120119 | ||
Apoptosis in the failing human heart | Q73215232 | ||
Histopathology of in-stent restenosis in patients with peripheral artery disease | Q73303005 | ||
Angiotensin II induces apoptosis of adult ventricular myocytes in vitro | Q73342683 | ||
Thrombin generation by apoptotic vascular smooth muscle cells | Q73436777 | ||
Apoptosis and carcinogenesis | Q73888683 | ||
Heat shock induces IkappaB-alpha and prevents stress-induced endothelial cell apoptosis | Q73951331 | ||
Regulators of apoptosis in the heart: a matter of life and death | Q74461634 | ||
Tumor necrosis factor-alpha contributes to ischemia- and reperfusion-induced endothelial activation in isolated hearts | Q74583470 | ||
Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury | Q77312084 | ||
Use of human tissue specimens obtained by directional atherectomy to study restenosis | Q83230159 | ||
Stretch-induced programmed myocyte cell death | Q35766096 | ||
Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. | Q35773800 | ||
Expression of NF-kappa B and I kappa B-alpha by aortic endothelium in an arterial injury model | Q35774140 | ||
Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. | Q35782561 | ||
Evidence for apoptosis in human atherogenesis and in a rat vascular injury model | Q35796023 | ||
Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme | Q35796049 | ||
Cytokine mRNA expression in postischemic/reperfused myocardium. | Q35796148 | ||
Cell death by apoptosis and its protective role against disease | Q36327633 | ||
Bcl-2 inhibits the mitochondrial release of an apoptogenic protease | Q36367392 | ||
Programmed cell death: apoptosis and oncogenesis. | Q36399233 | ||
Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells | Q36607485 | ||
Inflammation in the course of early myocardial ischemia | Q37238694 | ||
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion | Q37353803 | ||
Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis | Q37355284 | ||
Apoptosis in pressure overload-induced heart hypertrophy in the rat. | Q37356640 | ||
Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death | Q37362206 | ||
p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes | Q37368100 | ||
Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo | Q37375494 | ||
Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell | Q37380055 | ||
Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells | Q38289804 | ||
Vascular smooth muscle cells express a constitutive NF-kappa B-like activity | Q38302342 | ||
NF-kappa B is induced in the nuclei of cultured rat aortic smooth muscle cells by stimulation of various growth factors | Q38355566 | ||
Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity | Q38357897 | ||
Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53 | Q39790463 | ||
Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats | Q39791860 | ||
Role of oxidized low density lipoprotein in atherogenesis | Q40343074 | ||
The ins and outs of programmed cell death during C. elegans development | Q40585908 | ||
The comet assay: a comprehensive review | Q40604761 | ||
Mechanisms and genes of cellular suicide | Q40605270 | ||
The oxidation hypothesis of atherosclerosis | Q40625668 | ||
Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias | Q40668908 | ||
Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants | Q40732007 | ||
Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation | Q40851731 | ||
Does reperfusion injury exist in humans? | Q40871834 | ||
The bcl-2 family of proteins | Q40910555 | ||
Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. | Q40938362 | ||
Role of translocases in the generation of phosphatidylserine asymmetry | Q41004464 | ||
Molecular thanatopsis: a discourse on the BCL2 family and cell death. | Q41025122 | ||
Fas-induced activation of the cell death-related protease CPP32 Is inhibited by Bcl-2 and by ICE family protease inhibitors | Q41185116 | ||
Events in apoptosis. Acidification is downstream of protease activation and BCL-2 protection | Q41186069 | ||
Basic mechanisms in heart failure: the cytokine hypothesis | Q41188647 | ||
Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis | Q41204766 | ||
Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases | Q41224926 | ||
Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation | Q41417507 | ||
Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calcium-dependent pathways in lymphoblastoid cells. | Q41438394 | ||
Contributions of ischemia and reperfusion to mucosal lesion formation | Q41469735 | ||
Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis | Q41559705 | ||
Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. | Q41575182 | ||
Complex causes of fatal myocardial infarction | Q41604782 | ||
Integrins and anoikis | Q41612562 | ||
P433 | issue | 2 | |
P921 | main subject | apoptotic process | Q14599311 |
cardiovascular disease | Q389735 | ||
P304 | page(s) | 132-140 | |
P577 | publication date | 2001-04-01 | |
P1433 | published in | Irish Journal of Medical Science | Q6070885 |
P1476 | title | The role of apoptotic cell death in cardiovascular disease | |
P478 | volume | 170 |